针对非小细胞肺癌的瘤微环境特异性疗法的当前状况
Raghav Chandra1, Jasmina Ehab2, Edward Hauptmann1
1Department of Surgery, University of Texas Southwestern Medical Center, Dallas, TX 75390, USA.
Cancers
|June 13, 2025
概括
针对瘤微环境 (TME) 的免疫疗法已经彻底改变了非小细胞肺癌 (NSCLC) 治疗. 进一步探索TME目标有望为NSCLC患者带来更好的治疗效益.
科学领域:
- 在瘤学瘤学.
- 免疫学 免疫学 免疫学
- 胸部外科手术 胸部外科手术
背景情况:
- 非小细胞肺癌 (NSCLC) 是癌症死亡的主要原因.
- 免疫疗法,特别是抗PD-1/PD-L1检查点抑制剂,显著改善了晚期NSCLC的结果.
- 这些疗法越来越多地用于早期NSCLC的外科治疗.
研究的目的:
- 审查NSCLC瘤微环境 (TME) 中当前的治疗目标.
- 讨论免疫疗法在NSCLC中的影响和未来方向.
- 探索TME特定的目标调查如何影响胸部外科护理.
主要方法:
- 关于NSCLC瘤微环境和免疫治疗的当前文献的综述.
- 分析临床进展和未来的治疗策略.
- 讨论对胸部外科手术的影响.
主要成果:
- 免疫疗法改变了NSCLC的治疗方法,改善了晚期疾病的存活率.
- NSCLC TME为新型治疗策略提供了许多潜在的目标.
- 调查TME特异性点对于推进NSCLC治疗,包括手术管理至关重要.
结论:
- 针对NSCLCTME,特别是通过免疫疗法,代表了癌症治疗的范式转变.
- 对TME特定点的持续研究对于开发更有效的疗法至关重要.
- 了解TME动态对于优化胸部手术在NSCLC管理中的作用至关重要.
更多相关视频
07:59Author Spotlight: Advancements in Molecular Biomarker Testing for Non-Squamous Non-Small Cell Lung Cancer
Published on: September 8, 2023
1.0K
04:04Endobronchial Ultrasound-guided Intratumoral Injection of Cisplatin for the Treatment of Isolated Mediastinal Recurrence of Lung Cancer
Published on: February 12, 2017
10.4K
相关概念视频
The Tumor Microenvironment
6.6K
Every normal cell or tissue is embedded in a complex local environment called stroma, consisting of different cell types, a basal membrane, and blood vessels. As normal cells mutate and develop into cancer cells, their local environment also changes to allow cancer progression. The tumor microenvironment (TME) consists of a complex cellular matrix of stromal cells and the developing tumor. The cross-talk between cancer cells and surrounding stromal cells is critical to disrupt normal tissue...
6.6K
Targeted Cancer Therapies
7.5K
The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against...
There are several types of targeted therapies against...
7.5K
Tumor Immunotherapy
493
Immunotherapy is a treatment that boosts or manipulates the immune system to fight diseases, including cancer. For instance, by stimulating an immune response through vaccinations against viruses that cause cancers, like hepatitis B virus and human papillomavirus, these diseases can be prevented. Nonetheless, some cancer cells can avoid the immune system due to their rapid mutation and division. The immune response to many cancers involves three phases: elimination, equilibrium, and escape.
493
Cancer Therapies
7.6K
Cancer therapies are various modes of treatment, such as surgery, radiation therapy, and chemotherapy that are administered to cancer patients.
However, cancer treatments can pose several challenges, as therapies used to kill cancer cells are generally also toxic to normal cells. Moreover, cancer cells mutate rapidly and can develop resistance to chemical agents or radiation therapy. Besides, all types of cancer cells may not respond to the same therapy. Some cancer cells respond to one...
However, cancer treatments can pose several challenges, as therapies used to kill cancer cells are generally also toxic to normal cells. Moreover, cancer cells mutate rapidly and can develop resistance to chemical agents or radiation therapy. Besides, all types of cancer cells may not respond to the same therapy. Some cancer cells respond to one...
7.6K
Combination Therapies and Personalized Medicine
4.9K
Combining two or more treatment methods increases the life span of cancer patients while reducing damage to vital organs or tissue from the overuse of a single treatment. Combination therapy also targets different cancer-inducing pathways, thus reducing the chances of developing resistance to treatment.
The combination of the drug acetazolamide and sulforaphane is a good example of combination therapy to treat cancer. The cells in the interior of a large tumor often die due to the hypoxic and...
The combination of the drug acetazolamide and sulforaphane is a good example of combination therapy to treat cancer. The cells in the interior of a large tumor often die due to the hypoxic and...
4.9K
Treatment Resistant Cancers
3.3K
Cancer is the second leading cause of death in the United States. A cancer cell is genetically unstable and hence can mutate faster. They can also modify their microenvironment and escape immune surveillance. The difficulties in treating cancer are further compounded by the emergence of rapid resistance to anticancer drugs. The most common ways to attain resistance in cancer cells include alteration in drug transport and metabolism, modification of drug target, elevated DNA damage response, or...
3.3K
